Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FKUQN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,015
Award facts
- Contract value 100% obligated
- $22,014.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,014.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vraylar 3 mg capsules (quantity: 30 count). This non-competitive delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. Vraylar is a branded psychiatric medication used to treat schizophrenia and bipolar disorder, and this delivery supports the company's role as a critical pharmaceutical vendor for federal military healthcare systems.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's comprehensive medical supply chain, fulfilling pharmaceutical needs across the Department of Defense, Defense Health Agency, and other federal healthcare systems. The company's DLA prime indefinite delivery contract functions as a global pharmaceutical support vehicle enabling flexible procurement of brand-name and generic medications, specialty drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order reflects the routine fulfillment of federal pharmaceutical requirements through AmerisourceBergen's established contract vehicle supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FKUQN?
SPE2DB25FKUQN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FKUQN worth?
The government has obligated $22,015 on SPE2DB25FKUQN.
Is contract SPE2DB25FKUQN an order under another contract?
Yes. SPE2DB25FKUQN is a delivery order under SPE2DB24D3014, an indefinite delivery contract.
Was contract SPE2DB25FKUQN competed?
The extent of competition for SPE2DB25FKUQN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award